InnovAge
INNV
$5.99
Share price
-1.32%
Change (1 day)
39.30%
Change (1 year)
Categories
InnovAge (INNV) - P/B ratio
P/B ratio as of October 2023 : 2.53
According to InnovAge's latest financial reports the company has a price-to-book ratio of 2.53.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
InnovAge - P/B ratio (from 2021 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 2.93 | 59.53% |
| 2021-12-31 | 1.84 | |
| 2020-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Merck MRK | 5.64 | 122.78% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | 0.5720 | -77.42% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | 0.9237 | -63.53% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | 4.99 | 96.95% | 🇮🇪 Ireland |